USIran Military Exchanges Escalate for Second Time in Days Raising Geopolitical Risks Ofcom Flags TikTok and YouTube as Not Safe Enough for Children Raising Regulatory Stakes Markets SixWeek Record Run Top and Bottom Performers in the Club Portfolio Lowes Signals Consumer Caution as Home Improvement Demand Shifts Fed Minutes Signal Potential Rate Hikes if Iran War Continues to Fuel Inflation Nifty Consolidation Continues Amid Weak Market Breadth Analysts Eye Banking and IT Sectors GS Q1 2026 Earnings EPS Beat Despite Revenue Uncertainty Trading Strength Propels Results First Watch Restaurant Group Inc FWRG Q1 2026 Earnings EPS Miss Slightly Weighs on Sentiment WKHS Q1 2026 Earnings Deeper Losses on Zero Revenue Highlight EV Startups Cash Challenges EXLS Q1 2026 Earnings EPS Surpasses Estimates by 62 Amid Optimistic Outlook ONBPP Q1 2026 Earnings Slight EPS Miss Flat Stock Reaction for Old National Bancorp Preferred RCI Hospitality Holdings RICK Q3 2025 Earnings EPS Misses Estimates by 636 Stock Declines Artelo Biosciences ARTL Slides 105 as Shares Test Key Support Levels BEPI Inches Higher as Perpetual Note Holds Steady Above Support Kolibri Global Energy KGEI Gains Over 35 as It Approaches Key Resistance Level BioXcel Therapeutics BTAI Slips 088 as Stock Tests Support Near 107 Eastern Bankshares EBC Gains 18 as Stock Nears Key Technical Resistance TIMB Q1 2026 Earnings EPS Misses Estimates as Operational Challenges Persist WTTR Q1 2026 Earnings EPS Surges Past Estimates Stock Declines Despite Strong Beat ATHR Q1 2026 Earnings NarrowerThanExpected Loss Signals Improved Cost Management NXTC Q1 2026 Earnings SmallerthanExpected Loss but Stock Plunges 22 as Revenue Stays at Zero ARE Q1 2026 Earnings Massive EPS Surprise Highlights Operational Strength CLDT Q1 2026 Earnings NarrowerThanExpected Loss Amid Operational Discipline Nvidia Earnings Call in Focus CEO Jensen Huang May Address China Chip Restrictions and Trump Policy After Xi Summit Nexxen International Q3 2025 Earnings EPS Surges Past Estimates on Operating Efficiency Candel Therapeutics CADL Attempts Recovery as Stock Nears Resistance